High-yield overview
Resistance to PTH - and the Short Metacarpal
PTH resistanceLow Ca, high PO4, HIGH PTH
GNAS / Gs-alphaImprinted gene defect
AHOShort 4th/5th metacarpals + more
PHP vs PPHPMaternal (resistant) vs paternal (not)
The GNAS spectrum
PHP type 1a
PatternMATERNAL Gs-alpha (GNAS) loss-of-function: AHO phenotype + multi-hormone resistance (PTH, TSH->hypothyroid, gonadotropins). Hypocalcaemia, hyperphosphataemia, high PTH.
Treatment
PHP type 1b
PatternUsually a maternal GNAS METHYLATION (imprinting) defect: PTH (+/- TSH) resistance, typically WITHOUT (or minimal) AHO features.
Treatment
PHP type 1c
PatternAHO + hormone resistance with normal Gs-alpha activity on standard assay.
Treatment
Pseudo-pseudohypoparathyroidism (PPHP)
PatternPATERNAL GNAS mutation: AHO phenotype WITHOUT hormone resistance (NORMAL calcium/PTH).
Treatment
Critical Must-Knows
- Pseudohypoparathyroidism (PHP) is END-ORGAN RESISTANCE to PARATHYROID HORMONE: the parathyroid glands work and secrete PTH, but the kidney and bone do not respond, so the biochemical hallmark is HYPOCALCAEMIA and HYPERPHOSPHATAEMIA with a HIGH (not low) PTH - the opposite of true hypoparathyroidism (where PTH is low).
- The defect is in GNAS, which encodes the alpha subunit of the stimulatory G protein (Gs-alpha) that couples the PTH receptor to adenylate cyclase/cAMP; because GNAS is an IMPRINTED gene, the PARENT OF ORIGIN of the mutation determines the phenotype.
- PHP type 1a (MATERNALLY inherited Gs-alpha loss) gives the ALBRIGHT HEREDITARY OSTEODYSTROPHY (AHO) phenotype PLUS resistance to multiple hormones (PTH, and also TSH causing hypothyroidism, and gonadotropins); PSEUDO-PSEUDOHYPOPARATHYROIDISM (PPHP, PATERNALLY inherited) gives the same AHO physical phenotype but WITHOUT hormone resistance (normal calcium and PTH).
- The AHO phenotype is high-yield: SHORT STATURE, a ROUND ('moon') FACE, OBESITY, BRACHYDACTYLY - characteristically SHORTENED 4th and 5th METACARPALS (and metatarsals) - SUBCUTANEOUS OSSIFICATIONS/calcifications, and variable developmental delay; on clenching a fist the short 4th/5th metacarpals form DIMPLES rather than knuckles (the positive 'metacarpal sign', 'knuckle-knuckle-dimple-dimple').
- DIAGNOSIS combines the biochemistry (low calcium, high phosphate, HIGH PTH, with low/normal vitamin D), the AHO physical features and hand/foot radiographs (short 4th/5th metacarpals/metatarsals, the positive metacarpal sign), and GNAS molecular/methylation testing; associated hormone resistance (e.g. high TSH/hypothyroidism) should be sought.
- MANAGEMENT of the hypocalcaemia is ORAL CALCIUM and ACTIVE VITAMIN D (calcitriol/alfacalcidol) to normalise calcium and lower PTH (PTH resistance means standard vitamin D alone is insufficient), plus treatment of any associated hormone deficiencies (e.g. levothyroxine for hypothyroidism), monitoring for hypercalciuria, and genetic counselling; the skeletal/brachydactyly features themselves rarely need surgery.
Clinical Pearls
- “PHP = PTH RESISTANCE: low calcium + high phosphate + HIGH PTH (vs hypoparathyroidism = low PTH).
- “GNAS/Gs-alpha, IMPRINTED: maternal = PHP1a (AHO + hormone resistance); paternal = PPHP (AHO only, normal biochemistry).
- “AHO: short stature, round face, obesity, SHORT 4th/5th metacarpals (metacarpal sign), subcutaneous ossifications. Treat hypocalcaemia with calcium + active vitamin D.
High PTH with Low Calcium = Resistance
Pseudohypoparathyroidism
Low calcium, high phosphate, HIGH PTH (target-organ resistance). GNAS/Gs-alpha defect. AHO features in PHP1a.
Hypoparathyroidism (contrast)
Low calcium, high phosphate, LOW PTH (gland failure). No AHO phenotype. (Pseudo-PHP = AHO look with NORMAL biochemistry.)
Mechanism & Imprinting
The Target Can't Hear the Hormone
PTH normally binds its receptor and, via Gs-alpha (encoded by GNAS), activates adenylate cyclase and cAMP to raise calcium and excrete phosphate. In PHP, a Gs-alpha defect means the kidney and bone are resistant to PTH, so calcium falls and phosphate rises, and the parathyroids respond by secreting more PTH - hence the paradoxical high PTH with low calcium. Because GNAS is imprinted (expressed differently from the maternal and paternal alleles in some tissues), the parent of origin of the mutation shapes the phenotype: a MATERNAL defect (PHP type 1a) causes both AHO and hormone resistance, whereas a PATERNAL defect (PPHP) causes the AHO physical phenotype without hormone resistance.
Phenotype, Biochemistry & Diagnosis
AHO Features and the Lab Triad
- AHO phenotype: short stature, round/moon face, obesity, brachydactyly with short 4th/5th metacarpals/metatarsals (the metacarpal sign), subcutaneous ossifications/calcifications, and variable developmental delay/intellectual impairment; basal-ganglia calcification may be seen.
- Biochemistry (PHP 1a/1b): LOW calcium, HIGH phosphate, HIGH PTH, with low/normal 1,25-vitamin D - the high PTH distinguishing it from hypoparathyroidism (low PTH). PPHP has the AHO look but NORMAL calcium and PTH.
- Imaging: hand/foot radiographs show short 4th/5th metacarpals/metatarsals and the positive metacarpal sign; subcutaneous ossifications and intracranial (basal ganglia) calcification may be present.
- Genetics: GNAS sequencing and methylation analysis (for PHP1b imprinting defects) confirm the diagnosis and clarify the subtype; screen for associated hormone resistance (e.g. TSH/hypothyroidism).
- Clinical signs of hypocalcaemia (Chvostek/Trousseau, tetany, seizures, cataracts) may be the presentation.
Management
Calcium + Active Vitamin D, and Treat the Other Resistances
- Correct the hypocalcaemia: oral calcium plus ACTIVE vitamin D (calcitriol or alfacalcidol), because PTH resistance impairs renal 1-alpha-hydroxylation, so ordinary vitamin D is insufficient; titrate to a low-normal calcium and a falling PTH, monitoring for hypercalciuria/nephrocalcinosis.
- Manage associated hormone resistance: levothyroxine for TSH resistance/hypothyroidism, and address gonadotropin resistance/growth as needed.
- Genetic counselling: explain the GNAS imprinting and parent-of-origin risk to offspring.
- Orthopaedic: the brachydactyly and short stature seldom require surgery; manage symptomatic subcutaneous ossifications and address any functional issues; coordinate care with endocrinology.
Don't Mistake the PTH
The pitfall is treating PHP as ordinary hypoparathyroidism or as vitamin-D-deficiency hypocalcaemia. The high PTH with low calcium and high phosphate is the giveaway that this is resistance, not gland failure, and it requires active vitamin D (calcitriol) rather than plain vitamin D. Recognise the AHO phenotype (short stature, round face, short 4th/5th metacarpals) and screen for other hormone resistances (especially hypothyroidism), and remember that a relative with the AHO look but normal biochemistry has pseudo-pseudohypoparathyroidism.
Evidence & Key Studies
Evidence
Three-generation familial transmission of a GNAS variant: evolving PHP/PPHP phenotype
Demertzidou E, Ververi A, Tournis S, et al. • Hormones (Athens) (2025)
Key Findings:
- GNAS variants cause pseudohypoparathyroidism (types 1a/1b/1c) and pseudo-pseudohypoparathyroidism, with complex imprinting and parent-of-origin phenotypic variability.
- Affected family members showed Albright hereditary osteodystrophy features (short stature, brachydactyly, round face, obesity); the neonate with the maternally transmitted variant developed PHP1a features (AHO, high PTH, transient hypothyroidism).
- The mother's phenotype resembled PPHP (normocalcaemia, elevated PTH), illustrating how the same GNAS variant produces resistant (PHP) versus non-resistant (PPHP) phenotypes by parent of origin.
Evidence
Novel variants and clinical heterogeneity in paediatric calcium metabolism disorders (tiered genetic testing)
Kang TY, Chou YY, Chang YM, Pan YW, Tsai MC • Medicina (Kaunas) (2025)
Key Findings:
- In a paediatric calcium-metabolism cohort, PTH resistance (pseudohypoparathyroidism) was among the diagnoses, with GNAS implicated.
- A stepwise (tiered) genetic-testing strategy gave a high diagnostic yield and expanded the mutational spectrum.
- Precise molecular diagnosis is important for management and genetic counselling in these rare disorders.
Evidence Attribution
According to PubMed, the GNAS imprinting basis, the PHP-subtype/PPHP distinction by parent of origin and the AHO features come from the cited Demertzidou family report, and the role of genetic testing (GNAS) in diagnosing PTH resistance from the cited Kang cohort. The PTH-resistance biochemistry (high PTH with hypocalcaemia/hyperphosphataemia), the brachydactyly/metacarpal sign and the calcium/active-vitamin-D treatment are standard, well-established teaching. (See also our Calcium Homeostasis / Metabolic Bone and Hypophosphatasia topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
Viva scenarioStandard
Clinical prompt
“A short patient with a round face and short ring and little knuckles has low calcium, high phosphate and a HIGH PTH. What is the diagnosis and the underlying mechanism?”
Practical approach
The combination of hypocalcaemia and hyperphosphataemia with a high - rather than low - parathyroid hormone, in a patient with the physical features of short stature, a round face and short fourth and fifth metacarpals, is pseudohypoparathyroidism with the Albright hereditary osteodystrophy phenotype. The mechanism is end-organ resistance to parathyroid hormone: the parathyroid glands secrete PTH normally, but the kidney and bone cannot respond because of a defect in GNAS, which encodes the alpha subunit of the stimulatory G protein that couples the PTH receptor to adenylate cyclase and cAMP. So calcium falls and phosphate rises, and the glands respond by secreting even more PTH, giving the paradoxical high PTH with low calcium. GNAS is an imprinted gene, so the parent of origin matters: a maternally inherited Gs-alpha defect, type 1a, causes the AHO phenotype plus resistance to multiple hormones, including TSH causing hypothyroidism, whereas a paternally inherited defect causes pseudo-pseudohypoparathyroidism, the same AHO physical appearance but with normal calcium and PTH. The short fourth and fifth metacarpals produce dimples instead of knuckles when the patient makes a fist - the positive metacarpal sign. I would confirm with hand radiographs and GNAS genetic and methylation testing, and screen for associated hormone resistance such as hypothyroidism.
Key clinical points
Pseudohypoparathyroidism = PTH RESISTANCE: low Ca + high PO4 + HIGH PTH (vs hypoPTH = low PTH)
GNAS/Gs-alpha defect couples PTH receptor to cAMP; gland works, target resists
Imprinted: maternal = PHP1a (AHO + multi-hormone resistance); paternal = PPHP (AHO only, normal biochemistry)
AHO: short stature, round face, obesity, short 4th/5th metacarpals (metacarpal sign), subcutaneous ossifications
Common pitfalls
Calling it hypoparathyroidism (PTH would be LOW)
Forgetting the imprinting/parent-of-origin distinction (PHP vs PPHP)
Missing associated hypothyroidism (TSH resistance)
Further questions
“Why is PTH high? - End-organ resistance; glands secrete more PTH (gland works, target resists)”
“What does PPHP show biochemically? - AHO phenotype but NORMAL calcium and PTH (paternal)”
Viva scenarioStandard
Clinical prompt
“How would you confirm and manage pseudohypoparathyroidism?”
Practical approach
I would confirm the diagnosis by combining the biochemistry, the phenotype and genetics. The biochemistry shows hypocalcaemia, hyperphosphataemia and a high PTH with a low or normal active vitamin D, which indicates resistance rather than gland failure. The phenotype is Albright hereditary osteodystrophy - short stature, a round face, obesity, brachydactyly with short fourth and fifth metacarpals and metatarsals, subcutaneous ossifications and sometimes developmental delay - and hand and foot radiographs show the short metacarpals and the positive metacarpal sign, with subcutaneous and basal-ganglia calcification sometimes present. I would confirm with GNAS sequencing and methylation analysis to define the subtype, and screen for associated hormone resistance, particularly TSH resistance causing hypothyroidism. Management centres on correcting the hypocalcaemia with oral calcium and active vitamin D, that is calcitriol or alfacalcidol, because PTH resistance impairs renal activation of vitamin D so plain vitamin D is insufficient; I would titrate to a low-normal calcium with a falling PTH while monitoring for hypercalciuria and nephrocalcinosis. I would treat associated deficiencies, for example levothyroxine for hypothyroidism, provide genetic counselling about the imprinting and the risk to offspring, and coordinate care with endocrinology; the brachydactyly itself rarely needs surgery.
Key clinical points
Confirm: biochemistry (low Ca, high PO4, high PTH) + AHO phenotype + radiographs + GNAS sequencing/methylation
Screen for other hormone resistance (TSH/hypothyroidism)
Treat hypocalcaemia with calcium + ACTIVE vitamin D (calcitriol) - plain vitamin D insufficient
Monitor hypercalciuria/nephrocalcinosis; treat associated deficiencies; genetic counselling
Common pitfalls
Using plain vitamin D instead of calcitriol
Not screening for hypothyroidism
Over-treating to hypercalciuria/nephrocalcinosis
Further questions
“Which vitamin D form is needed and why? - Active (calcitriol); PTH resistance impairs renal 1-alpha-hydroxylation”
“What test defines PHP1b? - GNAS methylation (imprinting) analysis”
Mnemonics & Memory Aids
Mnemonic
RESIST
R
Resistance to PTH (target organ)
E
Elevated PTH (with low calcium)
S
Short 4th/5th metacarpals (metacarpal sign)
I
Imprinted GNAS (maternal PHP1a vs paternal PPHP)
S
Subcutaneous ossifications; Short stature/round face
T
Treat with calcium + active vitamin D (+ thyroxine)
Hook:PHP = RESIST: the target resists PTH, so PTH is high.
Mnemonic
PHP vs PPHP
M
Maternal GNAS = PHP1a = AHO + hormone resistance (low Ca, high PTH)
P
Paternal GNAS = PPHP = AHO phenotype only (normal Ca/PTH)
Hook:Maternal = PHP (resistant); Paternal = Pseudo-PHP (look only).
Exam day cheat sheet
Pseudohypoparathyroidism / AHO - Exam Day Cheat Sheet
Mechanism & biochemistry
- End-organ RESISTANCE to PTH (GNAS/Gs-alpha defect)
- Low calcium + high phosphate + HIGH PTH (vs hypoPTH = low PTH)
- Imprinted GNAS: maternal = PHP1a; paternal = PPHP
Subtypes
- PHP1a: AHO + multi-hormone resistance (PTH, TSH, gonadotropins)
- PHP1b: PTH (+/- TSH) resistance, minimal/no AHO (methylation defect)
- PPHP: AHO phenotype WITHOUT hormone resistance (normal Ca/PTH)
AHO phenotype
- Short stature, round/moon face, obesity, developmental delay
- Brachydactyly - short 4th/5th metacarpals/metatarsals (metacarpal sign)
- Subcutaneous ossifications; basal-ganglia calcification
Diagnosis & management
- Biochemistry + AHO features + hand/foot radiographs + GNAS sequencing/methylation
- Treat hypocalcaemia: oral calcium + ACTIVE vitamin D (calcitriol)
- Treat associated resistance (levothyroxine); monitor hypercalciuria; genetic counselling